Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Calmoseptine vs Destin for Incontinence Associated Dermatitis
NCT02080247Phase 3Completed
- Sponsor
- University of the Philippines
- Start
- Dec 2012
- Primary completion
- Apr 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Calmoseptine in incontinence-associated dermatitis (IAD), sponsored by University of the Philippines. Started Dec 2012; status: completed.
02
Drugs
Calmoseptine
03
Conditions
incontinence-associated dermatitis (IAD)
Beyond the preview
Go deeper on NCT02080247.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02080247.